TFRC and myeloid sarcoma: This study provides novel evidence of a disturbed balance between suppressive and proinflammatory Treg and Tfr fractions, significantly lower expression of the transcription factor Helios across all Treg cell fractions and dysregulation of B cells at the first presentation of neurological events suggestive of MS (CIS).